P448: PROGNOSTIC SIGNIFICANCE OF MEASURABLE RESIDUAL DISEASE DETECTION BY FLOW CYTOMETRY IN AUTOLOGOUS STEM CELL APHERESIS PRODUCTS OF PATIENTS WITH AML

• Jesse Tettero,
• Yara Buisman,
• Lok Lam Ngai,
• Costa Bachas,
• Bjorn Tore Gjertsen,
• Angèle Kelder,
• Arjan van de Loosdrecht,
• Markus Manz,
• Thomas Pabst,
• Willemijn Scholten,
• Gert Ossenkoppele,
• Jacqueline Cloos,
• David de Leeuw

Affiliations

Jesse Tettero

1 Amsterdam UMC, location VUmc, Department of Hematology, Amsterdam, The Netherlands

Yara Buisman

1 Amsterdam UMC, location VUmc, Department of Hematology, Amsterdam, The Netherlands

Lok Lam Ngai

1 Amsterdam UMC, location VUmc, Department of Hematology, Amsterdam, The Netherlands

Costa Bachas

1 Amsterdam UMC, location VUmc, Department of Hematology, Amsterdam, The Netherlands

Bjorn Tore Gjertsen

2 Haukeland University Hospital, Department of Medicine, Hematology Section, Bergen, Norway

Angèle Kelder

1 Amsterdam UMC, location VUmc, Department of Hematology, Amsterdam, The Netherlands

Arjan van de Loosdrecht

1 Amsterdam UMC, location VUmc, Department of Hematology, Amsterdam, The Netherlands

Markus Manz

3 University Hospital of Zürich, Department of Medical Oncology and Hematology, Zürich, Switzerland

Thomas Pabst

4 Inselspital, University Hospital, Department of Medical Oncology, Bern, Switzerland

Willemijn Scholten

1 Amsterdam UMC, location VUmc, Department of Hematology, Amsterdam, The Netherlands

Gert Ossenkoppele

1 Amsterdam UMC, location VUmc, Department of Hematology, Amsterdam, The Netherlands

Jacqueline Cloos

1 Amsterdam UMC, location VUmc, Department of Hematology, Amsterdam, The Netherlands

David de Leeuw

1 Amsterdam UMC, location VUmc, Department of Hematology, Amsterdam, The Netherlands